Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-caesarean anemia iron treatment trial
NL-OMON44876Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postpartum anemia and iron deficiency anemia (IDA) comparing Oral ferrous fumarate, Intravenous Ferrinject and Placebo/control (3 arms). Primary endpoints: Hemoglobin level at 3 weeks postoperatively and Hemoglobin level at 6 weeks postoperatively. Started Mar 2015; status: active, not recruiting.
02
Drugs
ferric carboxymaltoseferrous fumarate
03
Conditions
postpartum anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON44876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44876.